Development of a Taste-Masked, Dose-Flexible, Multiparticulate Pediatric Dosage Form: Case Study of Crizotinib, a Challenging Pediatric Formulation.
Saved in:
| Title: | Development of a Taste-Masked, Dose-Flexible, Multiparticulate Pediatric Dosage Form: Case Study of Crizotinib, a Challenging Pediatric Formulation. |
|---|---|
| Authors: | Bartlett JA; Global Research and Development, Pharmaceutical Sciences, Pfizer Inc., Groton, CT, USA. jeremy.a.bartlett@pfizer.com., Culver N; Global Research and Development, Pharmaceutical Sciences, Pfizer Inc., Groton, CT, USA., Santangelo M; Global Research and Development, Pharmaceutical Sciences, Pfizer Inc., Groton, CT, USA., Prpich A; Global Research and Development, Pharmaceutical Sciences, Pfizer Inc., Groton, CT, USA., Long E; Global Research and Development, Pharmaceutical Sciences, Pfizer Inc., Groton, CT, USA., Sagawa K; Global Research and Development, Pharmaceutical Sciences, Pfizer Inc., Groton, CT, USA., Shanker R; Global Research and Development, Pharmaceutical Sciences, Pfizer Inc., Groton, CT, USA., Xu H; Global Research and Development, Clinical Pharmacology, Pfizer Inc., San Diego, CA, USA., Wilner K; Global Research and Development, Clinical, Pfizer Inc., San Diego, CA, USA. |
| Source: | Pharmaceutical medicine [Pharmaceut Med] 2026 May; Vol. 40 (3), pp. 193-207. Date of Electronic Publication: 2026 Apr 01. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 101471195 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1993 (Electronic) Linking ISSN: 11782595 NLM ISO Abbreviation: Pharmaceut Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41920422 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Development of a Taste-Masked, Dose-Flexible, Multiparticulate Pediatric Dosage Form: Case Study of Crizotinib, a Challenging Pediatric Formulation. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Bartlett+JA%22">Bartlett JA</searchLink>; Global Research and Development, Pharmaceutical Sciences, Pfizer Inc., Groton, CT, USA. jeremy.a.bartlett@pfizer.com.<br /><searchLink fieldCode="AU" term="%22Culver+N%22">Culver N</searchLink>; Global Research and Development, Pharmaceutical Sciences, Pfizer Inc., Groton, CT, USA.<br /><searchLink fieldCode="AU" term="%22Santangelo+M%22">Santangelo M</searchLink>; Global Research and Development, Pharmaceutical Sciences, Pfizer Inc., Groton, CT, USA.<br /><searchLink fieldCode="AU" term="%22Prpich+A%22">Prpich A</searchLink>; Global Research and Development, Pharmaceutical Sciences, Pfizer Inc., Groton, CT, USA.<br /><searchLink fieldCode="AU" term="%22Long+E%22">Long E</searchLink>; Global Research and Development, Pharmaceutical Sciences, Pfizer Inc., Groton, CT, USA.<br /><searchLink fieldCode="AU" term="%22Sagawa+K%22">Sagawa K</searchLink>; Global Research and Development, Pharmaceutical Sciences, Pfizer Inc., Groton, CT, USA.<br /><searchLink fieldCode="AU" term="%22Shanker+R%22">Shanker R</searchLink>; Global Research and Development, Pharmaceutical Sciences, Pfizer Inc., Groton, CT, USA.<br /><searchLink fieldCode="AU" term="%22Xu+H%22">Xu H</searchLink>; Global Research and Development, Clinical Pharmacology, Pfizer Inc., San Diego, CA, USA.<br /><searchLink fieldCode="AU" term="%22Wilner+K%22">Wilner K</searchLink>; Global Research and Development, Clinical, Pfizer Inc., San Diego, CA, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101471195%22">Pharmaceutical medicine</searchLink> [Pharmaceut Med] 2026 May; Vol. 40 (3), pp. 193-207. <i>Date of Electronic Publication: </i>2026 Apr 01. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Adis%2C+Springer+International%22">Adis, Springer International </searchLink><i>Country of Publication: </i>New Zealand <i>NLM ID: </i>101471195 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1179-1993 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2211782595%22">11782595 </searchLink><i>NLM ISO Abbreviation: </i>Pharmaceut Med <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41920422 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s40290-026-00604-2 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 193 Titles: – TitleFull: Development of a Taste-Masked, Dose-Flexible, Multiparticulate Pediatric Dosage Form: Case Study of Crizotinib, a Challenging Pediatric Formulation. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Bartlett JA – PersonEntity: Name: NameFull: Culver N – PersonEntity: Name: NameFull: Santangelo M – PersonEntity: Name: NameFull: Prpich A – PersonEntity: Name: NameFull: Long E – PersonEntity: Name: NameFull: Sagawa K – PersonEntity: Name: NameFull: Shanker R – PersonEntity: Name: NameFull: Xu H – PersonEntity: Name: NameFull: Wilner K IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 05 Text: 2026 May Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1179-1993 Numbering: – Type: volume Value: 40 – Type: issue Value: 3 Titles: – TitleFull: Pharmaceutical medicine Type: main |
| ResultId | 1 |